Paper Details

  1. Home
  2. Paper Details

Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.

Author: Lara-PadillaEleazar, Pizarro-CastellanosMariel, Reyes-GarcíaJuan Gerardo, Rizzoli-CórdobaAntonio, Rosado-PérezJuana, Soto-MolinaHerman, del Valle-LaisequillaCecilia Fernández

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Clinical Trial, Phase IIIA Phase III trial is a trial that further rigorously verifies the efficacy and safety of a new drug or treatment, whose efficacy and safety have been confirmed in a Phase II trial, in a large number of patients, and evaluates whether it is superior to existing treatments.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Amfepramone (diethylpropion) was found to be effective and well tolerated for weight loss in obese Mexican adults over a 6-month period.
Paper Details　
Original Abstract of the Article :
Amfepramone, also known as diethylpropion, is an anorectic drug used for the short-term treatment of obesity; however, its efficacy and safety during periods greater than 3 months has been scarcely studied. To evaluate the 6-month efficacy and safety of amfepramone treatment in obese adult Mexican p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.5414/CP202135

データ提供：米国国立医学図書館（NLM）

Six-Month Efficacy and Safety of Amfepramone in Obese Mexican Patients

This research investigates the efficacy and safety of amfepramone, an anorectic drug used for weight loss, in obese Mexican patients over a six-month period. The authors, like researchers meticulously testing a new drug in a clinical trial, conducted a double-blind, randomized, placebo-controlled trial involving 156 obese patients. The results demonstrate that amfepramone was effective in reducing body weight and improving anthropometric and metabolic parameters over six months, with a favorable safety profile.

Amfepramone: A Weight Loss Tool

This study, like a treasure map guiding us to a healthier weight, shows the potential of amfepramone as an effective and safe weight loss medication.

Navigating Weight Management

This research suggests that amfepramone may be a valuable tool for weight management in obese patients, but it is important to consult with a healthcare professional to assess individual risks and benefits.

Dr.Camel's Conclusion

This study provides important data on the efficacy and safety of amfepramone for weight loss, offering a potential treatment option for obese patients.

Date :
  1. Date Completed 2015-10-01
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

26073353

DOI: Digital Object Identifier

10.5414/CP202135

Related Literature

Article Analysis
・Effects of diethylpropion
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.